Aurora Cannabis Inc. (ACB) |
|
0.7045 -0.001 (-0.2%)
|
03-24 16:00 |
|
Open: |
0.7011 |
Pre. Close: |
0.7059 |
|
High:
|
0.7099 |
Low:
|
0.6905 |
|
Volume:
|
1,911,113 |
Market Cap:
|
240(M) |
|
|
|
Technical analysis |
as of: 2023-03-24 4:23:44 PM |
|
Overall:
|
 |
| Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 0.96  One year: 1.09 |
| Support: |
Support1: 0.65 Support2: 0.54 |
| Resistance: |
Resistance1: 0.82 Resistance2: 0.93 |
| Pivot: |
0.74 |
| Moving Average: |
MA(5): 0.7 MA(20): 0.76
MA(100): 1.02 MA(250): 1.53 |
| MACD: |
MACD(12,26): -0.1  Signal(9): -0.1 |
| Stochastic oscillator: |
%K(14,3): 24.5 %D(3): 24.6 |
| RSI: |
RSI(14): 35.7 |
| 52-week: |
High: 4.21 Low: 0.65 |
| Average Vol(K): |
3-Month: 6,413 (K) 10-Days: 4,142 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ ACB ] has closed above bottom band by 29.2%. Bollinger Bands are 38% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.71 - 0.72 |
0.72 - 0.72 |
|
Low:
|
0.68 - 0.68 |
0.68 - 0.69 |
|
Close:
|
0.7 - 0.71 |
0.71 - 0.71 |
|
Company Description |
|
Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada. |
Headline News |
Fri, 24 Mar 2023
Aurora Provides Update on Nasdaq Listing - PR Newswire
Tue, 21 Mar 2023
TLRY: Sell the Farm on These 4 Cannabis Stocks - StockNews.com
Mon, 20 Mar 2023
Aurora Cannabis Files Preliminary Base Shelf Prospectus - Aurora ... - Benzinga
Sat, 18 Mar 2023
Aurora Cannabis Inc. (TSE:ACB) Receives Consensus ... - MarketBeat
Fri, 17 Mar 2023
Aurora Cannabis Announces Filing of Preliminary Base Shelf ... - PR Newswire
Wed, 15 Mar 2023
Aurora Cannabis Inc. stock falls Wednesday, underperforms market - MarketWatch
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Drug Manufacturers—Specialty & Generic |
| Shares Out. |
341 (M) |
| Shares Float |
341 (M) |
|
% Held by Insiders
|
0 (%) |
|
% Held by Institutions
|
18 (%) |
|
Shares Short
|
34,140 (K) |
|
Shares Short P.Month
|
29,360 (K) |
Stock Financials |
|
EPS
|
-5.64 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
1.63 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
-109.7 |
|
Return on Assets (ttm)
|
-8.3 |
|
Return on Equity (ttm)
|
-137.3 |
|
Qtrly Rev. Growth
|
1.7 |
|
Gross Profit (p.s.)
|
0.06 |
|
Sales Per Share
|
0.62 |
|
EBITDA (p.s.)
|
-0.54 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-157 (M) |
|
Levered Free Cash Flow
|
-118 (M) |
Stock Valuations |
|
PE Ratio
|
-0.13 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0.42 |
|
Price to Sales
|
1.13 |
|
Price to Cash Flow
|
-1.53 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
2020-05-10 |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
